Glutaric aciduria type 1 presenting with epilepsy speech-language disorders: A case control study

Developmental Medicine and Child Neurology

Volumn 51, Issue 3, 2009, Pages 235-239

  Collins, Verity M ^a,d   Bakalino, Daniela B ^b   Hendriksz, Chris ^c   Singh, Ravi P ^b  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARNITINE; ETIRACETAM; GLUTARYL COENZYME A DEHYDROGENASE; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; CASE REPORT; CHILD; DIET THERAPY; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ENZYME DEFICIENCY; EPILEPSY; FAMILY HISTORY; FEMALE; GLUTARIC ACIDURIA TYPE 1; HUMAN; LOW DRUG DOSE; NOCTURNAL SEIZURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN RESTRICTION; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

EID: 64349084707     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2008.03240.x     Document Type: Article

References (21)

1. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type 1 glutaric aciduria, part 1: Natural history of 77 patients. Am J Med Genet 2003; 121C: 38-52.
2. Baric I, Zschocke J, Christensen E, et al. Diagnosis and management of glutaric aciduria type 1. J Inherit Metab Dis 1998; 21: 326-40.
3. Haworth JC, Booth FA, Chudley AE, et al. Phenotypic variability in glutaric aciduria type 1: Report of fourteen cases in five Canadian Indian kindreds. J Pediatr 1991; 118: 52-58.
4. Kyllerman M, Skjeldal OH, Lundberg M, et al. Dystonia and dyskinesia in glutaric aciduria type I: Clinical heterogeneity and therapeutic considerations. Mov Disord 1994; 9: 22-30.
5. Morton DH, Bennett MJ, Seargeant LE, Nichter CA, Kelley RI. Glutaric aciduria type I: A common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Genet 1991; 41: 89-95.
6. Land JM, Goulder P, Johnson A, Hockaday J. Glutaric aciduria type 1 an atypical presentation together with some observations upon treatment and the possible cause of cerebral damage. Neuropediatrics 1992; 23: 322-26.
7. Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT. Glutaric aciduria type I: Outcome in the Republic of Ireland. J Inherit Metab Dis 2004; 27: 917-20.
8. Twomey EL, Naughten ER, Donoghue VB, Ryan S. Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003; 33: 823-30.
9. Zafeirou DI, Zschocke J, Augoustidou-Savvopoulou P, et al. Atypical and variable clinical presentation of glutaric aciduria type I. Neuropediatrics 2000; 31: 303-06.
10. Collins J, Leonard JV. Natural history of glutaric aciduria type 1. Arch Dis Child 2000; 83: 87.[Comment]
11. Bahr O, Mader I, Zschocke J, Dichgans J, Schulz JB. Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology 2002; 59: 1802-04.
12. Pöge AP, Autschbach F, Korall H, Trefz FK, Mayatepek E. Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life. Acta Paediatr 1997; 86: 1144-47.
13. Osaka H, Kimura S, Nezu A, Yamazaki S, Saitoh K, Yamaguchi S. Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1. Brain Dev 1993; 15: 125-27.
14. Hartley LM, Khwaja OS, Verity CM. Glutaric aciduria type 1 and nonaccidental head injury. Pediatrics 2001; 107: 174-76.
15. Kolker A, Sauer SW, Surtees RAH, Leonard JV. The aetiology of neurological complications of organic acidaemias - a role for the blood-brain barrier. J Inherit Metab Dis 2006; 29: 701-04.
16. Wajner M, Kolker S, Souza DO, Hoffman GF, deMello CF. Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2004; 27: 825-28.
17. Lima TT, Begnini J, de Bastiani J, et al. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioural effects of glutaric acid. Brain Res 1998; 802: 55-60.
18. deMello CF, Kolker S, Ahlemeyer B, et al. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 2001; 916: 70-75.
19. Okamura N, Ohnishi S, Shimaoka H, Norikura R, Hasegawa H. Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by povalic acid and valproic acid. Pharm Res 2006; 23: 1729-35.
20. Zinnanti WJ, Lazovic J, Housman C, et al. Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 2007; 117: 3258-70.
21. Lin CM, Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 2007; 22: 105-09.